Prasad overrode FDA vaccine reviewers on Moderna’s Covid shot for young kidsnews2025-07-15T17:50:27+00:00July 15th, 2025|Endpoints News|
FDA questions the return of GSK’s Blenrep in multiple myeloma ahead of adcommnews2025-07-15T17:08:54+00:00July 15th, 2025|Endpoints News|
FDA employees let go in April receive final termination noticesnews2025-07-15T01:39:49+00:00July 15th, 2025|Endpoints News|
Makary pushes for lower user fees as agency kicks off PDUFA negotiationsnews2025-07-14T17:51:59+00:00July 14th, 2025|Endpoints News|
FDA rejects Ultragenyx’s Sanfilippo gene therapy over manufacturing issuesnews2025-07-14T11:38:31+00:00July 14th, 2025|Endpoints News|
Restrictions on Valneva’s chikungunya shot lifted in Europenews2025-07-11T17:35:22+00:00July 11th, 2025|Endpoints News|
FDA kicks off latest reauthorization of generic drug user fee legislationnews2025-07-11T17:12:20+00:00July 11th, 2025|Endpoints News|
FDA’s Makary floats idea of fast-review vouchers in return for lower US pricesnews2025-07-11T16:53:41+00:00July 11th, 2025|Endpoints News|
UK clears Bayer’s hot flash treatment, marking first approval worldwidenews2025-07-11T15:25:06+00:00July 11th, 2025|Endpoints News|
FDA hands Capricor a CRL for its Duchenne cell therapy news2025-07-11T11:26:27+00:00July 11th, 2025|Endpoints News|
